Optimization of therapy in secondary progressive multiple sclerosis; [Оптимизация терапии вторично-прогрессирующего рассеянного склероза]

The article provides an analysis of modern methods of treatment of secondary progressive multiple sclerosis (SPMS). The only drug that has proven its effectiveness in all types of SPMS (with exacerbations and without exacerbations) is siponimod. Clinical trials of this drug have proven its efficacy and safety in this type of MS. If the drug is included in the list of high-cost technologies, this modern method of treating SPMS can be made available to all patients who need it. © 2024 Ima-Press Publishing House. All rights reserved.

Authors
Boyko A.N. , Zyryanov S.K. , Vlasov Ya.V.
Journal
Nevrologiya, Neiropsikhiatriya, Psikhosomatika
Publisher
Ima-Press Publishing House
Language
Russian
Pages
88-90
State
Published
Link
External link
DOI
10.14412/2074-2711-2024-2S-88-90
Year
2024
Organizations
  • 1 N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, 1, Ostrovityanova St., Moscow, 117997, Russian Federation
  • 2 Federal Center of Brain and Neurotechnologies, FMBA of Russia, 1, Ostrovityanova St., Build. 10, Moscow, 117997, Russian Federation
  • 3 Peoples' Friendship University of Russia Named After Patrice Lumumba (RUDN University), 6, Miklukho-Maklaya St., Moscow, 117198, Russian Federation
  • 4 City Clinical Hospital No. 24, Moscow City Healthcare Department, 10, Pistsovaya St., Moscow, 127015, Russian Federation
  • 5 Samara State Medical University, Ministry of Health of Russia, 89, Chapaevskaya St., Samara, 443099, Russian Federation
Keywords
multiple sclerosis; secondary progressive multiple sclerosis; siponimod; treatment
Cite
ГОСТ MLA RIS BibTex
Share

Other records